Clinical Trial Update: A Study to Assess the Safety and Effects of Different Doses of an Investigational Drug, BAY 3389934, in Healthy Japanese Volunteers. [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial is evaluating the safety and effects of different doses of BAY 3389934 in healthy Japanese volunteers, with Sepsis Associated Dissemina…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis Associated Disseminated Intravascular Coagulation

Drugs mentioned

• BAY 3389934

Snippet

Sponsor: Bayer | Conditions: Sepsis Associated Disseminated Intravascular Coagulation (DIC) | Phase 1 | Status: RECRUITING